Reference:
Abd El-Aziz, T. M., & Stockand, J. D.
(2020). Recent progress and challenges in drug development against
COVID-19 coronavirus (SARS-CoV-2) - an update on the status.Infect Genet Evol, 83 (1567-7257 (Electronic)), 104327. doi:
10.1016/j.meegid.2020.104327
Amanat, F., & Krammer, F. (2020).
SARS-CoV-2 Vaccines: Status Report. Immunity, 52 (4), 583-589.
doi: 10.1016/j.immuni.2020.03.007
Arabi, Y. A.-O., Mandourah, Y.,
Al-Hameed, F., Sindi, A. A., Almekhlafi, G. A., Hussein, M. A., . . .
Fowler, R. A. (2020). Corticosteroid Therapy for Critically Ill Patients
with Middle East Respiratory Syndrome. (1535-4970 (Electronic)).
Ashour, H. M., Elkhatib, W. F.,
Rahman, M., & Elshabrawy, H. A. (2020). Insights into the Recent 2019
Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus
Outbreaks. Pathogens, 9 (3), 186.
Bernheim, A., Mei, X., Huang, M.,
Yang, Y., Fayad, Z. A., Zhang, N., . . . Chung, M. (2020). Chest CT
Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration
of Infection. Radiology, 295 (3), 200463. doi:
10.1148/radiol.2020200463
Bhimraj, A., Morgan, R. L., Shumaker,
A. H., Lavergne, V., Baden, L., Cheng, V. C., . . . Falck-Ytter, Y.
(2020). Infectious Diseases Society of America Guidelines on the
Treatment and Management of Patients with COVID-19. LID -
10.1093/cid/ciaa478 [doi] LID - ciaa478. (1537-6591 (Electronic)).
Booth, C. M., Matukas Lm Fau -
Tomlinson, G. A., Tomlinson Ga Fau - Rachlis, A. R., Rachlis Ar Fau -
Rose, D. B., Rose Db Fau - Dwosh, H. A., Dwosh Ha Fau - Walmsley, S. L.,
. . . Detsky, A. S. (2020). Clinical features and short-term outcomes of
144 patients with SARS in the greater Toronto area. (0098-7484 (Print)).
Cao, B., Wang, Y., Wen, D., Liu, W.,
Wang, J., Fan, G., . . . Wang, C. (2020). A Trial of Lopinavir-Ritonavir
in Adults Hospitalized with Severe Covid-19. N Engl J Med,
382 (19), 1787-1799. doi: 10.1056/NEJMoa2001282
Chan-Yeung, M. (2004). Severe acute
respiratory syndrome (SARS) and healthcare workers. Int J Occup
Environ Health, 10 (4), 421-427. doi: 10.1179/oeh.2004.10.4.421
Chaolin, H., Yeming, W., Xingwang,
L., Lili, R., Jianping, Z., Yi, H., . . . Bin, C. (2020). Clinical
features of patients infected with 2019 novel coronavirus in Wuhan,
China. The Lancet (Pre-publis).
Chaomin, W. (2020). Risk Factors
Associated With Acute Respiratory Distress Syndrome and Death in
Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.JAMA Internal Medicine .
Chappell, B. (2020). CORONAVIRUS:
COVID-19 IS NOW OFFICIALLY A PANDEMIC.
Chen, H., Guo, J., Wang, C., Luo, F.,
Yu, X., Zhang, W., . . . Zhang, Y. (2020). Clinical characteristics and
intrauterine vertical transmission potential of COVID-19 infection in
nine pregnant women: a retrospective review of medical records.Lancet, 395 (10226), 809-815. doi: 10.1016/S0140-6736(20)30360-3
CHEN Jun, L. D., LIU Li, LIU Ping, XU
Qingnian, XIA Lu, LING Yun, HUANG Dan, SONG Shuli, ZHANG Dandan, QIAN
Zhiping, LI Tao, SHEN Yinzhong, LU Hongzhou. (2020). A pilot study of
hydroxychloroquine in treatment of patients with common coronavirus
disease-19 (COVID-19).
Chen, N., Zhou, M., Dong, X., Qu, J.,
Gong, F., Han, Y., . . . Zhang, L. (2020). Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. Lancet, 395 (10223), 507-513.
doi: 10.1016/S0140-6736(20)30211-7
Cheng, Y., Wong R Fau - Soo, Y. O.
Y., Soo Yo Fau - Wong, W. S., Wong Ws Fau - Lee, C. K., Lee Ck Fau - Ng,
M. H. L., Ng Mh Fau - Chan, P., . . . Cheng, G. (2020). Use of
convalescent plasma therapy in SARS patients in Hong Kong. (0934-9723
(Print)).
Chersich, M. F., Gray, G., Fairlie,
L., Eichbaum, Q., Mayhew, S., Allwood, B., . . . Rees, H. (2020).
COVID-19 in Africa: care and protection for frontline healthcare
workers. Global Health, 16 (1), 46. doi:
10.1186/s12992-020-00574-3
Commission., C. N. H. (accessed 2020
Apr 12). Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and
Treatment (7thed). fromhttp://kjfy.meetingchina.org/msite/news/show/cn/3337.html
Coondoo, A., Phiske, M., Verma, S.,
& Lahiri, K. (2014). Side-effects of topical steroids: A long overdue
revisit. Indian dermatology online journal, 5 (4), 416-425. doi:
10.4103/2229-5178.142483
Costanzo, M., De Giglio, M. A. R., &
Roviello, G. N. (2020). SARS-CoV-2: Recent Reports on Antiviral
Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir,
Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the
Treatment of the New Coronavirus. LID -
10.2174/0929867327666200416131117 [doi]. (1875-533X (Electronic)).
Cui, J. A.-O., Li, F., & Shi, Z.
A.-O. X. Origin and evolution of pathogenic coronaviruses. (1740-1534
(Electronic)).
Cullen, W., Gulati, G., & Kelly, B.
D. (2020). Mental health in the COVID-19 pandemic. QJM, 113 (5),
311-312. doi: 10.1093/qjmed/hcaa110
de Wit, E., Feldmann, F., Cronin, J.,
Jordan, R., Okumura, A., Thomas, T., . . . Feldmann, H. (2020).
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the
rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S
A, 117 (12), 6771-6776. doi: 10.1073/pnas.1922083117
Deng, S. Q., & Peng, H. A.-O.
(2020). Characteristics of and Public Health Responses to the
Coronavirus Disease 2019 Outbreak in China. LID - 10.3390/jcm9020575
[doi] LID - 575. (2077-0383 (Print)).
Duan, K., Liu, B., Li, C., Zhang, H.,
Yu, T., Qu, J., . . . Yang, X. (2020). Effectiveness of convalescent
plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S
A, 117 (17), 9490-9496. doi: 10.1073/pnas.2004168117
Eisenberg, J. (2020). R0: How
Scientists Quantify the Intensity of an Outbreak Like Coronavirus and
Its Pandemic Potential.
Elfiky, A. A. (2020). Anti-HCV,
nucleotide inhibitors, repurposing against COVID-19. Life Sci,
248 , 117477. doi: 10.1016/j.lfs.2020.117477
Epidemiology Working Group for Ncip
Epidemic Response, C. C. f. D. C., & Prevention. (2020). [The
epidemiological characteristics of an outbreak of 2019 novel coronavirus
diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za
Zhi, 41 (2), 145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003
Esposito, S., Noviello, S., &
Pagliano, P. (2020). Update on treatment of COVID-19: ongoing studies
between promising and disappointing results. (1124-9390 (Print)).
Evans, A. S. (2013). Viral
infections of humans: epidemiology and control : Springer Science &
Business Media.
Ferner, R. E., & Aronson, J. K.
(2020). Chloroquine and hydroxychloroquine in covid-19. Bmj,
369 (1756-1833 (Electronic)), m1432. doi: 10.1136/bmj.m1432
Gamage, B., Moore, D., Copes, R.,
Yassi, A., Bryce, E., & Group, B. C. I. R. P. S. (2005). Protecting
health care workers from SARS and other respiratory pathogens: a review
of the infection control literature. Am J Infect Control, 33 (2),
114-121. doi: 10.1016/j.ajic.2004.12.002
Gorbalenya, A. E. (2020). Severe
acute respiratory syndrome-related coronavirus–The species and its
viruses, a statement of the Coronavirus Study Group. BioRxiv .
Grein, J., Ohmagari, N., Shin, D.,
Diaz, G., Asperges, E., Castagna, A., . . . Flanigan, T. (2020).
Compassionate Use of Remdesivir for Patients with Severe Covid-19. LID -
10.1056/NEJMoa2007016 [doi] LID - NEJMoa2007016. (1533-4406
(Electronic)).
Guan, W. J., Ni, Z. Y., Hu, Y.,
Liang, W. H., Ou, C. Q., He, J. X., . . . China Medical Treatment Expert
Group for, C. (2020). Clinical Characteristics of Coronavirus Disease
2019 in China. N Engl J Med, 382 (18), 1708-1720. doi:
10.1056/NEJMoa2002032
Health., D.-G. f. (2020). COVID-19:
mitigation phase. Approach of the patient with suspicion or infection
with SARS-CoV-2., from
https://www.dgs.pt/directrizes-da-dgs/normas-e-circulares-normativas/norma-n-0042020-de-23032020-pdf
Huang, C., Wang, Y., Li, X., Ren, L.,
Zhao, J., Hu, Y., . . . Cao, B. (2020). Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet,
395 (10223), 497-506. doi: 10.1016/S0140-6736(20)30183-5
Huang, J. Z., Han, M. F., Luo, T. D.,
Ren, A. K., & Zhou, X. P. (2020). [Mental health survey of medical
staff in a tertiary infectious disease hospital for COVID-19].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 38 (3), 192-195.
doi: 10.3760/cma.j.cn121094-20200219-00063
Imai, K., Tabata, S., Ikeda, M.,
Noguchi, S., Kitagawa, Y., Matuoka, M., . . . Maeda, T. Clinical
evaluation of an immunochromatographic IgM/IgG antibody assay and chest
computed tomography for the diagnosis of COVID-19. (1873-5967
(Electronic)).
Jakhar, D. A.-O., & Kaur, I. (2020).
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes
fears of shortages among people with systemic lupus erythematosus.
(1546-170X (Electronic)).
Jie, C., Fang, L., & Zheng-Li, S.
(2019). Origin and evolution of pathogenic coronaviruses. Nature
reviews. Microbiology, 17 (3).
Jin, Y. H., Cai, L., Cheng, Z. S.,
Cheng, H., Deng, T., Fan, Y. P., . . . Health, C. (2020). A rapid advice
guideline for the diagnosis and treatment of 2019 novel coronavirus
(2019-nCoV) infected pneumonia (standard version). Mil Med Res,
7 (1), 4. doi: 10.1186/s40779-020-0233-6
Juurlink, D. N. (2020). Safety
considerations with chloroquine, hydroxychloroquine and azithromycin in
the management of SARS-CoV-2 infection. Cmaj, 192 (17), E450-E453.
doi: 10.1503/cmaj.200528
Kang, S., Peng, W., Zhu, Y., Lu, S.,
Zhou, M., Lin, W., . . . Deng, M. (2020). Recent progress in
understanding 2019 novel coronavirus (SARS-CoV-2) associated with human
respiratory disease: detection, mechanisms and treatment. Int J
Antimicrob Agents, 55 (5), 105950. doi:
10.1016/j.ijantimicag.2020.105950
Kaplan, S. S., & Hicks, C. B.
(2005). Lopinavir/ritonavir in the treatment of human immunodeficiency
virus infection. Expert Opin Pharmacother, 6 (9), 1573-1585. doi:
10.1517/14656566.6.9.1573
Keeling, M. J., & Rohani, P. (2011).Modeling infectious diseases in humans and animals : Princeton
University Press.
Kim, C. J., Choi, W. S., Jung, Y.,
Kiem, S., Seol, H. Y., Woo, H. J., . . . Kim, Y. S. (2020). Surveillance
of the MERS Coronavirus Infection in Healthcare Workers after Contact
with Confirmed MERS Patients: Incidence and Risk Factors of MERS-CoV
Seropositivity. Clinical Microbiology & Infection the Official
Publication of the European Society of Clinical Microbiology &
Infectious Diseases , S1198743X16302415.
Kimberly E. Hanson, A. M. C., Cesar
A. Arias. (2020). Infectious Diseases Society of America Guidelines on
the Diagnosis of COVID-19.
Kisely, S., Warren, N., McMahon, L.,
Dalais, C., Henry, I., & Siskind, D. (2020). Occurrence, prevention,
and management of the psychological effects of emerging virus outbreaks
on healthcare workers: rapid review and meta-analysis. Bmj,
369 (1756-1833 (Electronic)), m1642. doi: 10.1136/bmj.m1642
Kristensen, K. E., Torppedersen, C.,
Gislason, G. H., Egfjord, M., Rasmussen, H. B., & Hansen, P. R. (2015).
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor
Blockers in Patients With Abdominal Aortic AneurysmsSignificance.Arterioscler Thromb Vasc Biol, 35 (3), 733-740.
Kuba, K., Imai, Y., Rao, S., Gao, H.,
Guo, F., Guan, B., . . . Deng, W. (2020). A crucial role of angiotensin
converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury.11 (8), 875-879.
Lee, B. Y. (2020). Study: 17.9% Of
People With COVID-19 Coronavirus Had No Symptoms.
Lentini, G. A.-O., Cavalluzzi, M. M.,
& Habtemariam, S. A.-O. (2020). COVID-19, Chloroquine Repurposing, and
Cardiac Safety Concern: Chirality Might Help. LID - E1834 [pii] LID
- 10.3390/molecules25081834 [doi]. (1420-3049 (Electronic)).
Li-Li, R., Ye-Ming, W., Zhi-Qiang,
W., Zi-Chun, X., Li, G., Teng, X., . . . Jian-Wei, W. (2020).
Identification of a novel coronavirus causing severe pneumonia in human:
a descriptive study. Chinese medical journal .
Li G Fau - De Clercq, E., & De
Clercq, E. Therapeutic options for the 2019 novel coronavirus
(2019-nCoV). (1474-1784 (Electronic)).
Li G Fau - De Clercq, E., & De
Clercq, E. (2020). Therapeutic options for the 2019 novel coronavirus
(2019-nCoV). (1474-1784 (Electronic)).
Li, W., Yang, Y., Liu, Z. H., Zhao,
Y. J., Zhang, Q., Zhang, L., . . . Xiang, Y. T. (2020). Progression of
Mental Health Services during the COVID-19 Outbreak in China. Int
J Biol Sci, 16 (10), 1732-1738. doi: 10.7150/ijbs.45120
Li, Z., Yi, Y., Luo, X., Xiong, N.,
Liu, Y., Li, S., . . . Ye, F. (2020). Development and clinical
application of a rapid IgM-IgG combined antibody test for SARS-CoV-2
infection diagnosis. LID - 10.1002/jmv.25727 [doi]. (1096-9071
(Electronic)).
Linton, N. M., Kobayashi, T., Yang,
Y., Hayashi, K., Akhmetzhanov, A. R., Jung, S.-m., . . . Nishiura, H.
(2020). Epidemiological characteristics of novel coronavirus infection:
A statistical analysis of publicly available case data. medRxiv .
Luigi Angelo, V., Giovanni, S., &
Giacomo De, R. (2020). The importance of olfactory and gustatory
disorders as early symptoms of coronavirus disease (COVID-19).British Journal of Oral and Maxillofacial Surgery .
Macau., U. o. (2020). UM professional
team works with government to provide psychological counselling during
epidemic period., from https:
//wwwumedumo/news-centre/news-and-events/news-and-press-releases/detail/49950/#news_title
(access February 17, 2020). 2020
Malta, M., Rimoin, A. W., &
Strathdee, S. A. (2020). The coronavirus 2019-nCoV epidemic: Is
hindsight 20/20? (2589-5370 (Electronic)).
Marto, N., & Monteiro, E. C. (2020).
Medicines for the Treatment Of COVID-19: Awaiting the Evidence. LID -
10.20344/amp.13908 [doi]. (1646-0758 (Electronic)).
Medicine, N. H. C. S. A. o. T. C.
(2020). Diagnosis and Treatment Protocol for Novel Coronavirus
Pneumonia.
medicine, P. S. o. c. (2020).
Recommendations of the Portuguese Society of intensive care and group
infection and sepsis on the method of covid-19., from
https://www.spci.pt/media/covid-19/COVID_19_R_20200331.pdf.
Natsuko Imai, A. C., Ilaria
Dorigatti, Marc Baguelin, Christl A. Donnelly, Steven Riley, Neil M.
Ferguson. (2020). Report 3: Transmissibility of 2019-nCoV.
Nurses, T. I. C. o. (2020). ICN calls
for data on healthcare worker infection rates and deaths.
P, W. A. C., Xin, L., P, L. S. K., &
Y, W. P. C. (2019). Global Epidemiology of Bat Coronaviruses.Viruses, 11 (2).
Peng, X., Xu, X., Li, Y., Cheng, L.,
Zhou, X., & Ren, B. (2020). Transmission routes of 2019-nCoV and
controls in dental practice. Int J Oral Sci, 12 (1), 9. doi:
10.1038/s41368-020-0075-9
Pereira, B. A.-O. (2020). Challenges
and cares to promote rational use of chloroquine and hydroxychloroquine
in the management of coronavirus disease 2019 (COVID-19) pandemic: a
timely review. (1521-6950 (Electronic)).
Pranab, C., Nazia, N., Anup, A.,
Bhabatosh, D., & Raman, R. G. (2020). The 2019 novel coronavirus
disease (COVID-19) pandemic: A review of the current evidence. The
Indian Journal of Medical Research .
Rempenault, C., Combe, B., Barnetche,
T., Gaujoux-Viala, C., Lukas, C., Morel, J., & Hua, C. (2020).
Metabolic and cardiovascular benefits of hydroxychloroquine in patients
with rheumatoid arthritis: a systematic review and meta-analysis.
(1468-2060 (Electronic)).
Ren, L. L., Wang, Y. M., Wu, Z. Q.,
Xiang, Z. C., Guo, L., Xu, T., . . . Wang, J. W. (2020). Identification
of a novel coronavirus causing severe pneumonia in human: a descriptive
study. Chin Med J (Engl), 133 (9), 1015-1024. doi:
10.1097/CM9.0000000000000722
Rothan, H. A., & Byrareddy, S. N.
(2020). The epidemiology and pathogenesis of coronavirus disease
(COVID-19) outbreak. J Autoimmun, 109 , 102433. doi:
10.1016/j.jaut.2020.102433
Savarino A Fau - Di Trani, L., Di
Trani L Fau - Donatelli, I., Donatelli I Fau - Cauda, R., Cauda R Fau -
Cassone, A., & Cassone, A. (2020). New insights into the antiviral
effects of chloroquine. (1473-3099 (Print)).
Schmid, M. B., & Fontijn, J. (2020).
COVID-19 in pregnant women. LID - S1473-3099(20)30175-4 [pii] LID -
10.1016/S1473-3099(20)30175-4 [doi] FAU - Schmid, Manuel B.
(1474-4457 (Electronic)).
Shajahan, A., Supekar, N. T.,
Gleinich, A. S., & Azadi, P. (2020). Deducing the N- and O-
glycosylation profile of the spike protein of novel coronavirus
SARS-CoV-2. LID - cwaa042 [pii] LID - 10.1093/glycob/cwaa042
[doi]. (1460-2423 (Electronic)).
Shen, C., Wang, Z., Zhao, F., Yang,
Y., Li, J., Yuan, J., . . . Liu, L. (2020). Treatment of 5 Critically
Ill Patients With COVID-19 With Convalescent Plasma.Jama (1538-3598 (Electronic)). doi: 10.1001/jama.2020.4783
Shen, K., Yang, Y., Wang, T., Zhao,
D., Jiang, Y., Jin, R., . . . Lin, L. (2020). Diagnosis, treatment, and
prevention of 2019 novel coronavirus infection in children: experts’
consensus statement. World Journal of Pediatrics , 1-9.
Shigemura, J., Ursano, R. J.,
Morganstein, J. C., Kurosawa, M., & Benedek, D. M. (2020). Public
responses to the novel 2019 coronavirus (2019-nCoV) in Japan: Mental
health consequences and target populations. Psychiatry Clin
Neurosci, 74 (4), 281-282. doi: 10.1111/pcn.12988
World Health Organization
declares Global Emergency: A review of the 2019 Novel Coronavirus
(COVID-19) , (2020).
Stower, H. (2020).
Lopinavir-ritonavir in severe COVID-19. Nat Med, 26 (4), 465. doi:
10.1038/s41591-020-0849-9
Sun, J., He, W. T., Wang, L., Lai,
A., Ji, X., Zhai, X., . . . Su, S. (2020). COVID-19: Epidemiology,
Evolution, and Cross-Disciplinary Perspectives. Trends Mol Med,
26 (5), 483-495. doi: 10.1016/j.molmed.2020.02.008
Sun, P., Lu, X., Xu, C., Sun, W., &
Pan, B. (2020). Understanding of COVID‐19 based on current evidence.Journal of medical virology .
Sun, Z., Thilakavathy, K., Kumar, S.
S., He, G., & Liu, S. V. (2020). Potential Factors Influencing Repeated
SARS Outbreaks in China. Int J Environ Res Public Health, 17 (5),
1633. doi: 10.3390/ijerph17051633
Surveillances, V. (2020). The
Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus
Diseases (COVID-19)-China, 2020. fromhttp://weekly.chinacdc.cn/en/article/id
Tian, S., Hu, W., Niu, L., Liu, H.,
Xu, H., & Xiao, S. Y. (2020). Pulmonary Pathology of Early-Phase 2019
Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.J Thorac Oncol, 15 (5), 700-704. doi: 10.1016/j.jtho.2020.02.010
Tiwari, R., Dhama, K., Sharun, K.,
Iqbal Yatoo, M., Malik, Y. S., Singh, R., . . . Rodriguez-Morales, A. J.
(2020). COVID-19: animals, veterinary and zoonotic links. Vet Q,
40 (1), 169-182. doi: 10.1080/01652176.2020.1766725
Udugama, B., Kadhiresan, P.,
Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., . . .
Chan, W. C. W. (2020). Diagnosing COVID-19: The Disease and Tools for
Detection. ACS Nano, 14 (4), 3822-3835. doi:
10.1021/acsnano.0c02624
van Griensven, J., Edwards T Fau - de
Lamballerie, X., de Lamballerie X Fau - Semple, M. G., Semple Mg Fau -
Gallian, P., Gallian P Fau - Baize, S., Baize S Fau - Horby, P. W., . .
. Haba, N. (2020). Evaluation of Convalescent Plasma for Ebola Virus
Disease in Guinea. (1533-4406 (Electronic)).
Wang, D., Hu, B., Hu, C., Zhu, F.,
Liu, X., Zhang, J., . . . Xiong, Y. (2020). Clinical characteristics of
138 hospitalized patients with 2019 novel coronavirus–infected
pneumonia in Wuhan, China. Jama .
Wang, D., Hu, B., Hu, C., Zhu, F.,
Liu, X., Zhang, J., . . . Peng, Z. (2020). Clinical Characteristics of
138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia
in Wuhan, China. Jama (1538-3598 (Electronic)). doi:
10.1001/jama.2020.1585
Wang, H. J., Du, S. H., Yue, X., &
Chen, C. X. (2020). Review and Prospect of Pathological Features of
Corona Virus Disease. Fa Yi Xue Za Zhi, 36 (1), 16-20. doi:
10.12116/j.issn.1004-5619.2020.01.004
Wang, M., Cao, R., Zhang, L., Yang,
X., Liu, J., Xu, M., . . . Xiao, G. (2020). Remdesivir and chloroquine
effectively inhibit the recently emerged novel coronavirus (2019-nCoV)
in vitro. Cell Res, 30 (3), 269-271. doi:
10.1038/s41422-020-0282-0
Wang, Y., Zhang, D., Du, G., Du, R.,
Zhao, J., Jin, Y., . . . Wang, C. (2020). Remdesivir in adults with
severe COVID-19: a randomised, double-blind, placebo-controlled,
multicentre trial. Lancet, 395 (10236), 1569-1578. doi:
10.1016/S0140-6736(20)31022-9
Warren, T. K., Jordan, R., Lo, M. K.,
Ray, A. S., Mackman, R. L., Soloveva, V., . . . Bavari, S. (2020).
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus
in rhesus monkeys. (1476-4687 (Electronic)).
WHO. (2020a). Coronavirus disease
(COVID-19) Situation Report. from
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200522-covid-19-sitrep-123.pdf?sfvrsn=5ad1bc3_4
WHO. (2020b). WHO launches global
megatrial of the four most promising coronavirus treatments. from
https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-four-most-promising-coronavirus-treatments
Wichmann, D., Sperhake, J. P.,
Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., . . . Kluge, S.
(2020). Autopsy Findings and Venous Thromboembolism in Patients With
COVID-19. LID - 10.7326/M20-2003 [doi]. (1539-3704 (Electronic)).
Wilson KC, C. S., Bai C, Rello J.
(2020). COVID-19: Interim guidance on management pending empirical
evidence; from an American Thoracic Society led international task
force. from
https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/covid-19-guidance.pdf
Wu, C., Chen, X., Cai, Y., Xia, J.,
Zhou, X., Xu, S., . . . Song, Y. (2020). Risk Factors Associated With
Acute Respiratory Distress Syndrome and Death in Patients With
Coronavirus Disease 2019 Pneumonia in Wuhan, China. LID -
10.1001/jamainternmed.2020.0994 [doi] LID - e200994. (2168-6114
(Electronic)).
Xiaobo, Y., Yuan, Y., Jiqian, X.,
Huaqing, S., Jia’an, X., Hong, L., . . . Department of Critical Care
Medicine, R. H. o. W. U. W. C. (2020). Clinical course and outcomes of
critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a
single-centered, retrospective, observational study. The Lancet
Respiratory Medicine, 8 (5).
Xie, M., & Chen, Q. (2020). Insight
into 2019 novel coronavirus - An updated interim review and lessons from
SARS-CoV and MERS-CoV. (1878-3511 (Electronic)).
Xu, X., Chen, P., Wang, J., Feng,
J., Zhou, H., Li, X., . . . Hao, P. (2020). Evolution of the novel
coronavirus from the ongoing Wuhan outbreak and modeling of its spike
protein for risk of human transmission. Sci China Life Sci,
63 (3), 457-460. doi: 10.1007/s11427-020-1637-5
Xu, X. W., Wu, X. X., Jiang, X. G.,
Xu, K. J., Ying, L. J., Ma, C. L., . . . Li, L. J. (2020). Clinical
findings in a group of patients infected with the 2019 novel coronavirus
(SARS-Cov-2) outside of Wuhan, China: retrospective case series.Bmj, 368 , m606. doi: 10.1136/bmj.m606
Xu, Z., Shi, L., Wang, Y., Zhang,
J., Huang, L., Zhang, C., . . . Wang, F. S. (2020). Pathological
findings of COVID-19 associated with acute respiratory distress
syndrome. Lancet Respir Med, 8 (4), 420-422. doi:
10.1016/S2213-2600(20)30076-X
Yang, X., Yu, Y., Xu, J., Shu, H.,
Xia, J., Liu, H., . . . Shang, Y. (2020). Clinical course and outcomes
of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a
single-centered, retrospective, observational study. Lancet Respir
Med, 8 (5), 475-481. doi: 10.1016/S2213-2600(20)30079-5
Ying, L., A, G. A., Annelies, W.-S.,
& Joacim, R. (2020). The reproductive number of COVID-19 is higher
compared to SARS coronavirus. Journal of travel medicine .
Yu, P. (2020). A Familial Cluster of
Infection Associated With the 2019 Novel Coronavirus Indicating Possible
Person-to-Person Transmission During the Incubation Period. (1537-6613
(Electronic)).
Zha, L., Li, S., Pan, L., Tefsen,
B., Li, Y., French, N., . . . Villanueva, E. V. (2020). Corticosteroid
treatment of patients with coronavirus disease 2019 (COVID-19).Med J Aust, 212 (9), 416-420. doi: 10.5694/mja2.50577
Zhang, W., Du, R. H., Li, B., Zheng,
X. S., Yang, X. L., Hu, B., . . . Zhou, P. (2020). Molecular and
serological investigation of 2019-nCoV infected patients: implication of
multiple shedding routes. Emerg Microbes Infect, 9 (1), 386-389.
doi: 10.1080/22221751.2020.1729071
Zhu, N., Zhang, D., Wang, W., Li,
X., Yang, B., Song, J., . . . Tan, W. (2020). A Novel Coronavirus from
Patients with Pneumonia in China, 2019. New England Journal of
Medicine .
Zu, Z. Y., Jiang, M. D., Xu, P. P.,
Chen, W., Ni, Q. Q., Lu, G. M., & Zhang, L. J. (2020). Coronavirus
Disease 2019 (COVID-19): A Perspective from China. Radiology ,
200490. doi: 10.1148/radiol.2020200490